Wednesday, February 28, 2018

Vietnam Clinical Laboratory Market Future Outlook to 2022: Ken Research

The report titled “Vietnam Clinical Laboratory Market Outlook to 2022- by Labs (Hospital Labs, Independent Labs and Physician Office Labs) and Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan)” provides a comprehensive analysis of Vietnam Clinical Laboratory Market by Labs (Hospital Labs, Independent Labs and Physician Office Labs) and Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan) along with company profiles of Medic Lab, VietLife and Hoan My. The report also covers Trends, Investment Model for Setting up a Diagnostic Laboratory, Analyst Recommendations and future outlook for Vietnam Clinical Laboratory Market.
Vietnam Clinical Laboratory Market Research
Vietnam Clinical Laboratory Market Size and Overview
Clinical laboratories market have grown from USD ~ million in 2012 to USD ~ million in 2017 at a five year CAGR of ~% during the period due to rise in incidence and prevalence of communicable and non-communicable disease in the country coupled with increase in disease awareness campaigns. The market witnessed a decline in growth during 2016 due to low hospital budget allocated towards laboratories and slow economic growth of the country; however, bounced back in 2017. Government and private spending on establishing new hospitals coupled with rise in hospitals expenditure on replacing obsolete imaging and diagnostic instruments have positively augmented the market for clinical laboratories. Owing to increase in insurance coverage, clinical laboratories, especially hospital laboratories have witnessed a rise in clinical lab tests.
Market Segmentation
By Labs (Hospital Labs, Independent Labs and Physician Office Labs): Hospital Labs dominated the clinical laboratory market structure in Vietnam generating highest revenue with a share of ~% in 2017. Public hospital labs are the largest segment in terms of volume and revenue. They are preferred due to high quality standards and reasonable cost. Private hospitals labs segment grew at the fastest pace due to rise in per capita healthcare expenditure and incline in insurance coverage. Independent laboratories contributed second highest revenue share of ~% in clinical laboratory market. Physician office labs generated least revenue share due to lack of investment in laboratory equipments and low reimbursements from insurance coverage.
By Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan): Lab test dominated the type of test in Vietnam clinical laboratory market in 2017 generating ~% revenue share due to increase in the number of lab tests conducted over the years in the country. X-Ray contributed second highest revenue share of ~% in the type of test in Vietnam clinical laboratory market with Red River Delta attributing highest number of X-rays in 2015. Ultrasound contributed third highest revenue share of ~% in the type of test in Vietnam clinical laboratory followed by CT Scan contributing ~% revenue share.
Future Outlook to Vietnam Clinical Laboratories Market
Vietnam Clinical Laboratory market is poised to grow at a healthy CAGR of ~% during 2017-2022, driven by plans to build new hospitals, upgrade existing public hospitals and greater budget allocation for lab services. The private sector will continue to attract the affluent population, fuelling growth of routine and specialized tests. Public hospitals are expected to lead the Vietnam Clinical Laboratory market in terms of revenue followed by the private hospital labs, independent labs and physician office labs. Key opportunities for future in the market include clinical test outsourcing to independent labs, private sector continuing to attract affluent population, rise in demand for screening of infectious diseases and others.
Key Topics Covered in the Report
Vietnam Clinical Laboratory Market Overview and Size
Vietnam Clinical Laboratory Market Growth drivers
Vietnam Clinical Laboratory Market Restraints
Vietnam Clinical Laboratory Market by Labs (Hospital Labs, Independent Labs and Physician Office Labs)
Vietnam Clinical Laboratory Market by Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan)
Comparative Analysis of Major Diagnostic Laboratories
Trends in Vietnam Clinical Laboratory Market
Investment Model for Setting up a Diagnostic Laboratory
Analyst Recommendations for Vietnam Clinical Laboratory Market
Future Outlook for Vietnam Clinical Laboratory Market
To know more on research methodology, price and other report related information, refer to below link:
Related Reports
Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

South Korea Global Defense Industry Market Size - Ken Research


South Korea is one of the major economies within Asia with a considerable amount of security issues, which calls for a firm security posture. To combat the challenge posed by a nuclear threat from North Korea, the need to replace obsolete military equipment, and a growing necessity for restructuring and modernization of the military, South Korea has introduced the Defense Reform Plan 2020 (DRP 2020) with the aim of transforming the military into a smaller but more capable force. South Korea maintained a reasonably constant defense budget in relation to growing GDP and defense expenditure during 2014–2018 grew at a CAGR of 5.72%. According to research report “Future of the South Korean Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2023”, Defense expenditure during 2019-2023 is expected to grow at a CAGR of 4.90%, reaching US$48.5 billion in 2023. The reduction in military personnel, acquisition of new technology, and a reduction in the reliance of imports are other factors that impact the dynamics of South Korea’s defense expenditure.
The country is expected to focus on developing capabilities to develop new weapon systems, with specific emphasis being given to projects such as laser weapons, unmanned ground vehicles, and unmanned surveillance vehicles, among others. The country is also expected to invest in developing dedicated infrastructure for testing defense equipment and other hi-tech weapon systems. South Korea aims to increase the efficiency of its defense industrial complex by means of encouraging robust cooperation with the country’s commercial sector in addition to enhancing technology transfer (spin-offs) from the military to the country’s private industries and vice versa to achieve a level of synergy between the two sectors. South Korea also plans to provide financial assistance for organizing various market exploration activities such as defense exhibitions. Moreover, it plans on extending support for increasing the country’s defense exports.    
South Korean homeland security (HLS) expenditure is expected to grow consistently during the forecast period. The cyber and defense threat from North Korea and China accentuate the need for the procurement of sophisticated security technology with the coordination of IT and reinstates the increasing demand for cloud-based security solutions.

Key Topics Considered in the Report

Global defense industry research
South Korea defense industry research
South Korea Defense expenditure
South Korea Defense Capital Expenditure
South Korea Per-Capita Defense Expenditure
South Korea Missile Systems Market Size
South Korea Fighters and Multi-role Aircraft
South Korea Defense Imports and Exports
South Korea Air force market
South Korea combat vehicle market
South Korea Air craft components market
South Korea defense industry Infrastructure
South Korea Defense Testing Facilities
Government expenditure on South Korea Defense Industry

To know more, click on the link below:


Related reports



Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Tuesday, February 27, 2018

Obese Population Indonesia Market size: Ken Research

Indonesia healthcare market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017. People across Indonesia are facing several health care issues due to sedentary lifestyle and fast food consumption habits, such as obesity, diabetes, and other cardiovascular diseases, which are demanding for technologically advanced healthcare infrastructure. The Indonesia healthcare market has increased on the account of increasing healthcare facilities, innovation in pharmaceutical manufacturers and clinical laboratory services and expansion of pharmacy retail chains across the country. The market has witnessed enhancing innovation in nutritional health segment, biopharmaceuticals and specialty pharmaceutical products.
Hospitals in the country contributed to the maximum share of overall healthcare market as of 2016. Over ~% of the market revenues were generated from the hospitals segment followed by the pharmaceutical market with ~% in 2017.
Indonesia Healthcare market revenue has increased from USD ~ billion in 2012 to USD ~ billion in 2017 primarily due to rising prevalence of non-communicable and lifestyle diseases including diabetes, asthma and heart disorders. The industry has undergone various deregulation programs which has encouraged foreign investment in the industry. Furthermore, increase in demand for generic medicines has led the major players in the industry to expand their production capabilities.
Indonesia Clinical Laboratory Market is in the growing stage. The market has grown at a CAGR of ~% during 2012 to 2017 with revenue estimated at USD ~ billion in 2017. The industry has witnessed expansion of private laboratory chains and use of advanced technology in order to provide high quality laboratory services. With the implementation of JKN, the demand for laboratory services has further increased. The public hospitals mostly perform routine test while the esoteric tests are outsourced to the private clinical laboratories.  Due to growing awareness amongst people about healthy living, private and public laboratories have witnessed an increase in walk in patients asking for routine checkups which is funded out of the patient’s pocket. Further, the major private laboratory chains have expanded their operations in terms of capacity and geographic presence. The six major private laboratories occupying ~% of the revenue share of Indonesia Private independent labs in 2016 are Prodia, Kimia Farma, Pramita, Cito, Parahita and BioMedika.
The public clinical labs have accounted for ~% of the revenue share in Indonesia clinical laboratory market in 2017. Private hospital labs have accounted for ~% in 2017 and private independent labs with ~% of the overall market. The laboratory chains have been the leading market players in Indonesia in 2016 with ~% of revenue in the overall private independent laboratory market in 2016. Single independent labs have contributed to their lower revenue share of ~% due to their restricted geographic presence.
Doctor Referrals have accounted for the largest share of ~% of the tests in Indonesia Private independent laboratory market in 2016. With growing awareness about chronic diseases and their treatment procedure increasing number of Indonesians have taken charge of their own health. This has led to an increase in number of walk-ins at medical laboratories which has registered ~% of the tests. This is followed by corporate clients with ~% of the tests and external referrals with ~% of the total tests in 2016
Routine tests have accounted for ~% of the revenue in Indonesia Private independent laboratory market in 2016. This is followed by esoteric tests with ~% and non laboratory tests with ~% of the overall private independent laboratory market.  Esoteric tests require a professional approach from highly-skilled technical personnel, often utilize more sophisticated technology, equipment or materials and are generally ordered less frequently than routine tests. Generally, margins for esoteric tests are higher as compared to routine tests.
Java, Sumatra, Bali, Jakarta and Palembang have together accounted for ~% of the revenue in the overall private laboratory market in 2016. This is driven by high rate of urbanization and more affluent population, which has created greater demand for private clinical laboratory testing services. Underdeveloped cities such as Sulawesi, Maluku and Kalimantan have together accounted for ~% of the revenue in 2016.
The UHC scheme has increased the demand for basic and specialized testing. Since public clinical labs are not equipped with the technology for specialized testing, such tests have been outsourced to private independent laboratories. Rising major illness of NCDs and CDs has driven the demand for cardiovascular tests, tumor markers, metabolic tests, malaria and TB tests. There has been an increase in middle to high income earners seeking preventive health check-ups. Health check-ups are driven by walk-in patients and corporate clients who have together contributed up to 50% of the total test volume of a private independent laboratory. In addition to this, it is expected that the number of people taking health check-ups to grow by 2.2% on a yearly basis as more emphasis is given to the promotion of preventive health checkups. Major laboratory chains such as Cito, Pramita and Prodia have hence introduced health check up packages for male, female, children, adolescents, and old age people. Further, there are packages for different diseases such as cancer, diabetes, cardiac, fertility and others. The market has witnessed introduction of wide range of tests from routine tests to more specialized tests, including genomic platform with multiplexing capabilities able to support different classes of patients with precise diagnosis and speed up treatment consultation.
The private independent clinical laboratory market is organized and is composed of both chain laboratories and stand-alone laboratories. The chain laboratories are the leading market players in Indonesia. The 6 major players in the industry are Prodia, Kimia Farma, Pramita, Cito, BioMedika and Parahita. They have together accounted for 71.2% of the revenue share in private independent laboratory market in 2017.  The major players compete on distribution network, product portfolio, advertising, technology, Prices and services
The clinical laboratory market is expected to reach USD 3.2 billion by 2022 growing at a CAGR of 11.5%. The major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. It is also expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories. Further, the industry will witness a rising trend towards precision medicine also known as personalized medicine. Further, the market for rapid tests will grow at a CAGR of 13% between 2016 and 2021 in Indonesia. The growth will be driven by factors such as increasing rate of infectious diseases such as dengue, malaria, hepatitis, and HIV, the government’s healthcare initiatives, and product advancements and innovations by rapid test manufacturers
Key Topics covered in the report:-
Clinical Laboratory Market Size Indonesia
Number of Public Clinical Labs Indonesia
Number of Private Hospital Labs Indonesia
Number of Private Independent Labs Indonesia
Indonesia Clinical Laboratory value Chain
Market Share of Major Players in Indonesia Clinical Laboratory Market
Number of Lab Tests in Indonesia
Major Laboratory Chains in Indonesia
Type of Customers in Indonesia Clinical Laboratory Market
Major Type of Clinical Laboratory Tests Indonesia
Prodia Competitors Indonesia
Healthcare Spending Indonesia
Obese Population Indonesia
Indonesia Healthcare Market Future
Clinical Laboratory Market Future Trends Indonesia
Trends in Indonesia Clinical Laboratory Market
Issues & Challenges in Indonesia Clinical Laboratory Market
Government Regulations in Indonesia Clinical Laboratory market
Number of healthcare Centers in Indonesia
Budget Allocation on Healthcare Indonesia
Major Companies Clinical Laboratory Market Indonesia 

For more information on the research report, refer to below link:


Related Reports by Ken Research





Contact :
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
+91-9015378249

Still Sparkling Wine Market In Eritrea: Databook To 2017 – Ken Research

Still And Sparkling Wine Market Research Report

"Still & Sparkling Wine Market in Eritrea: Databook to 2017" is the result of Canadean's extensive market research covering the Still & Sparkling Wine market in Eritrea. The report presents detailed historic and forecast data on the Still & Sparkling Wine consumption trends in Eritrea, offering consumption volume and value at market and category level. Bringing together Canadean's research, modeling, and analysis expertise to develop uniquely detailed market data, it allows both foreign and domestic companies to identify the market dynamics of overall spirits sales, and remain sensitive to those categories that will be in the ascendency in the coming years. Through its provision of authoritative and granular detail of the Still & Sparkling Wine market in Eritrea, this report fills the gaps in marketers' understanding of market trends and the components of change driving them. Thanks to its provision of comprehensive and granular insights into the Still & Sparkling Wine market in Eritrea, the report facilitates the confident updating of strategic and tactical plans.
Detailed category coverage is provided, covering two product segments that include: Sparkling Wine, Still Wine. Future forecasts allow marketers to understand the future pattern of market trends, from winners and losers to category dynamics, and thereby quickly and easily identify the key areas in which they want to compete in the future. This report will enable an accurate understanding of key trends in Eritrea Still & Sparkling Wine market, facilitating the promotion of growth in your business through its provision of comprehensive data. It will help you understand your own and your competitors' position in the market, allowing for the effective identification of lucrative areas for future competition.
Key Topics Covered in the Report:-
Still And Sparkling Wine Market in Eritrea Research Report
Eritrea Still And Sparkling Wine Market Forecast
Eritrea Still And Sparkling Wine Market Revenue
Eritrea Still And Sparkling Wine Market Size
Eritrea Still And Sparkling Wine Market Future Outlook
Eritrea Still And Sparkling Wine Market Analysis
Eritrea Still And Sparkling Wine Market Opportunities
Eritrea Still And Sparkling Wine Market Competition
Eritrea Still And Sparkling Wine Market Trends
Eritrea Still And Sparkling Wine Market Shares
Eritrea Still And Sparkling Wine Market Growth Analysis
Eritrea Still And Sparkling Wine Market Value
Still And Sparkling Wine Market in Eritrea
Sparkling Wine Market in Eritrea

For more information on the research report, refer to below link:

Related Reports:-

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

The Insurance Industry In Eritrea, Key Trends And Opportunities To 2019 – Ken Research

Insurance Industry in Eritrea
Timetric's 'The Insurance Industry in Eritrea, Key Trends and Opportunities to 2019' report provides detailed analysis of the market trends, drivers and challenges in the Eritrean insurance industry. It provides key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, total assets, total investment income and retentions during the review period (2010-2014) and forecast period (2014-2019). The report also analyzes distribution channels operating in the segment, gives a comprehensive overview of the Eritrean economy and demographics, and provides detailed information on the competitive landscape in the country. The report brings together Timetric's research, modeling and analysis expertise, giving insurers access to information on segment dynamics and competitive advantages, and profiles of insurers operating in the country. The report also includes details of insurance regulations, and recent changes in the regulatory structure. Timetric's 'The Insurance Industry in Eritrea, Key Trends and Opportunities to 2019' report provides in-depth market analysis, information and insights into the Eritrean insurance industry, including:
The Eritrean insurance industry's growth prospects by segment and category. A comprehensive overview of Eritrean economy and demographics. The detailed competitive landscape in the Eritrean insurance industry. The various distribution channels in the Eritrean insurance industry
Detailed regulatory policies of the Eritrean insurance industry. Analysis of natural hazards in Eritrean insurance industry. This report provides a comprehensive analysis of the insurance industry in Eritrea: It provides historical values for the Eritrean insurance industry for the report's 2010-2014 review period and projected figures for the 2014-2019 forecast period. It offers a detailed analysis of the key segments in the Eritrean insurance industry, along with market forecasts until 2019. It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, combined ratio, total assets, total investment income and retentions. It analyzes the various distribution channels in Eritrea. It profiles the top insurance companies in Eritrea and outlines the key regulations affecting them.

Make strategic business decisions using in-depth historic and forecast market data related to the Eritrean insurance industry and each segment and category within it. Understand the demand-side dynamics, key market trends and growth opportunities in the Eritrean insurance industry. Assess the competitive dynamics in the Eritrean insurance industry. Identify the growth opportunities and market dynamics in key segments. Gain insights into key regulations governing the Eritrean insurance industry and their impact on companies and the industry's future. The industry was led by the non-life segment, with 83.7% of the gross written premium in 2014, followed by personal accident and health insurance with 15.2%, and life insurance with 1.1%. With economic growth and rising consumer awareness, the Eritrean insurance industry is expected to record a forecast-period CAGR of 9.4%. The motor insurance category contributed 55.4% of the industry's gross written premium in 2014. The insurance industry in Eritrea consists of only one insurance company: NICE. Insurance penetration stood at 0.38% in 2014, primarily supported by the non-life segment.
Key Topics Covered in the Report:-
Insurance Industry In Eritrea Market Research Report
Insurance Industry In Eritrea Market Forecast
Insurance Industry In Eritrea Market Revenue
Insurance Industry In Eritrea Market Size
Insurance Industry In Eritrea Market Future Outlook
Insurance Industry In Eritrea Market Analysis
Insurance Industry In Eritrea Market Opportunities
Insurance Industry In Eritrea Market Competition
Insurance Industry In Eritrea Market Trends
Insurance Industry In Eritrea Market Shares
Insurance Industry In Eritrea Market Growth Analysis
Insurance Industry In Eritrea Market Value
Eritrea Insurance Market

For more information on the research report, refer to below link:

Related Reports By Ken Research:-


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Global Malaria Clinical Trials Market Future Outlook: Ken Research

GlobalData'sclinical trial report, Malaria Global Clinical Trials Review, H2, 2017" provides an overview of Malaria clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years

Key Topics Covered in the Report:
Global Malaria Clinical Trials Market Future Outlook
Global Malaria Clinical Trials Market Trends
Global Malaria Clinical Trials Market Size
Global Malaria Clinical Trials Market Forecast
Europe Malaria Clinical Trials Market Volume
Global Malaria Clinical Trials Market
US Malaria Clinical Trials Market SWOT Analysis
Global Malaria Clinical Trials Market Share
Global Malaria Clinical Trials Market Revenue
Global Malaria Clinical Trials Market Growth

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204